170 related articles for article (PubMed ID: 36770711)
21. Beta-glucan inhibits the genotoxicity of cyclophosphamide, adriamycin and cisplatin.
Tohamy AA; El-Ghor AA; El-Nahas SM; Noshy MM
Mutat Res; 2003 Nov; 541(1-2):45-53. PubMed ID: 14568293
[TBL] [Abstract][Full Text] [Related]
22. Acrocomia aculeata prevents toxicogenetic damage caused by the antitumor agent cyclophosphamide.
Magosso MF; Carvalho PC; Shneider BU; Pessatto LR; Pesarini JR; Silva PV; Correa WA; Kassuya CA; Muzzi RM; Oliveira RJ
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173316
[TBL] [Abstract][Full Text] [Related]
23. Ovarian damage from chemotherapy and current approaches to its protection.
Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
[TBL] [Abstract][Full Text] [Related]
24. Retinol palmitate against toxicogenic damages of antineoplastic drugs on normal and tumor cells.
de Carvalho RM; de Alencar MVOB; da Mata AMOF; de Lima RMT; Sousa de Aguiar RP; Silva Teixeira J; Correia Jardim Paz MF; Morais Chaves SK; Islam MT; Sousa JMCE; Pinheiro Ferreira PM; Melo Cavalcante AAC; Salehi B; Setzer WN; Sharifi-Rad J
Chem Biol Interact; 2020 Oct; 330():109219. PubMed ID: 32846153
[TBL] [Abstract][Full Text] [Related]
25. An oxovanadium(IV) complex protects murine bone marrow cells against cisplatin-induced myelotoxicity and DNA damage.
Basu A; Bhattacharjee A; Samanta A; Bhattacharya S
Drug Chem Toxicol; 2017 Jul; 40(3):359-367. PubMed ID: 27868436
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical analysis of apoptotic bone marrow cells after treatment of mice with WR-2721 and chemotherapeutic drugs.
Mazur L; Czyzewska A
Folia Histochem Cytobiol; 2001; 39(2):63-6. PubMed ID: 11374841
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes.
Nguyen QN; Zerafa N; Liew SH; Findlay JK; Hickey M; Hutt KJ
Mol Hum Reprod; 2019 Aug; 25(8):433-444. PubMed ID: 30953068
[TBL] [Abstract][Full Text] [Related]
28. Campomanesia adamantium extract induces DNA damage, apoptosis, and affects cyclophosphamide metabolism.
Martello MD; David N; Matuo R; Carvalho PC; Navarro SD; Monreal AC; Cunha-Laura AL; Cardoso CA; Kassuya CA; Oliveira RJ
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173259
[TBL] [Abstract][Full Text] [Related]
29. Salidroside, a Chemopreventive Glycoside, Diminishes Cytotoxic Effect of Cisplatin in Vitro.
Zduriencikova M; Cholujova D; Duraj J; Mastihubova M; Mastihuba V; Karnisova Potocka E; Galova E; Sevcovicova A; Klapakova M; Horvathova E
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):346-354. PubMed ID: 28889522
[TBL] [Abstract][Full Text] [Related]
30. DNA damage response in cisplatin-induced nephrotoxicity.
Zhu S; Pabla N; Tang C; He L; Dong Z
Arch Toxicol; 2015 Dec; 89(12):2197-205. PubMed ID: 26564230
[TBL] [Abstract][Full Text] [Related]
31. Sensitizing effects of an organovanadium compound during adjuvant therapy with cyclophosphamide in a murine tumor model.
Basu A; Bhattacharjee A; Ghosh P; Samanta A; Bhattacharya S
Biomed Pharmacother; 2017 Sep; 93():816-829. PubMed ID: 28711021
[TBL] [Abstract][Full Text] [Related]
32. Is cisplatin-induced cell death always produced by apoptosis?
Gonzalez VM; Fuertes MA; Alonso C; Perez JM
Mol Pharmacol; 2001 Apr; 59(4):657-63. PubMed ID: 11259608
[TBL] [Abstract][Full Text] [Related]
33. Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer.
Himmel LE; Lustberg MB; DeVries AC; Poi M; Chen CS; Kulp SK
Exp Toxicol Pathol; 2016 Oct; 68(9):505-515. PubMed ID: 27555377
[TBL] [Abstract][Full Text] [Related]
34. Antigenotoxic properties of chlorophyll b against cisplatin-induced DNA damage and its relationship with distribution of platinum and magnesium in vivo.
Serpeloni JM; Batista BL; Angeli JP; Barcelos GR; Bianchi Mde L; Barbosa F; Antunes LM
J Toxicol Environ Health A; 2013; 76(6):345-53. PubMed ID: 23557233
[TBL] [Abstract][Full Text] [Related]
35. Silybin B exerts protective effect on cisplatin-induced neurotoxicity by alleviating DNA damage and apoptosis.
Wang XL; Lin FL; Xu W; Wang C; Wang QQ; Jiang RW
J Ethnopharmacol; 2022 Apr; 288():114938. PubMed ID: 34999144
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the DNA repair host-mediated assay. II. Presence of genotoxic factors in various organs of mice treated with chemotherapeutic agents.
Kerklaan PR; Bouter S; van Elburg PE; Mohn GR
Mutat Res; 1986 Feb; 164(1):19-29. PubMed ID: 2419750
[TBL] [Abstract][Full Text] [Related]
37. Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics.
Cagnoni PJ; Matthes S; Day TC; Bearman SI; Shpall EJ; Jones RB
Bone Marrow Transplant; 1999 Jul; 24(1):1-4. PubMed ID: 10435726
[TBL] [Abstract][Full Text] [Related]
38. Sensitization of cisplatin therapy by a naphthalimide based organoselenium compound through modulation of antioxidant enzymes and p53 mediated apoptosis.
Ghosh P; Singha Roy S; Basu A; Bhattacharjee A; Bhattacharya S
Free Radic Res; 2015 Apr; 49(4):453-71. PubMed ID: 25730340
[TBL] [Abstract][Full Text] [Related]
39. Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide.
Wang Z; Zheng Q; Liu K; Li G; Zheng R
Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):411-5. PubMed ID: 16623867
[TBL] [Abstract][Full Text] [Related]
40. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
